- Laboratoires Théa Selects IQVIA OCE and OneKey to Accelerate Its Global Digital Transformation
- Q² Solutions, an IQVIA and Quest Diagnostics Joint Venture, Teams With Adaptive Biotechnologies to Market immunoSEQ® Assay, the Leading Quantitative Large-Scale Immunosequencing Solution
- Prescription Opioid Use in the U.S. has Declined by 60% from 2011 Peak, According to New Report from the IQVIA™ Institute for Human Data Science
- IQVIA and Servier Collaborate to Reinvent Clinical Development
- IQVIA Supports Collaborative Forum of Top Pharma Leaders to Advance the Use and Acceptance of Real World Evidence
- IQVIA’s Orchestrated Customer Engagement Platform Selected by Zentiva to Accelerate Digital Capabilities
- IQVIA Reports Third-Quarter 2020 Results, Raises Full-Year 2020 Guidance and Provides 2021 Outlook
More ▼
Key statistics
On Friday, IQVIA Holdings Inc (IQV:NYQ) closed at 187.79, -2.37% below its 52-week high of 192.34, set on Jan 12, 2021.
52-week range
Markit short selling activity
Open | 187.92 |
---|---|
High | 188.75 |
Low | 185.61 |
Bid | 189.10 |
Offer | 0.00 |
Previous close | 188.11 |
Average volume | 770.27k |
---|---|
Shares outstanding | 191.73m |
Free float | 189.70m |
P/E (TTM) | 210.94 |
Market cap | 36.32bn USD |
EPS (TTM) | 0.898 USD |
Data delayed at least 15 minutes, as of Jan 15 2021 21:10 GMT.
More ▼